References
- Hu X, Fujimoto J, Ying L, et al. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nat Commun. 2019:5;10(1):2978. doi: 10.1038/s41467-019-10877-8. Erratum in: Nat Commun. 2021;12;12(1):2888.
- Sami M, Fibi N. Mycobacterium avium Complex. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024; Feb 25.
- Pina-Oviedo S, Medeiros LJ, Li S, et al. Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. Mod Pathol. 2017;30(5):734-744. doi: 10.1038/modpathol.2016.235.
- Grinjth DE, Aksamit T, Brown-Elliott BA et al. An onjcial ATS/IDSA statement: Diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416.
- Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an onjcial ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J 2020; 56: 2000535, https://doi.org/10.1183/13993003.00535-2020.
- WHO Classification of Tumours Editorial Board. Thoracic tumours. Lyon (France): International Agency for Research on Cancer; 2021. (WHO classification of tumours series, 5th ed.; vol. 5).
- Kadata K, Villena-Vargas J, Yoshizawa A, et al. Prognostic Significance of Adenocarcinoma in situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients with Stage I Disease. Am J Surg Pathol. 2014; 38(4): 448–460.
- Strand T, Rostad H, Strøm E, Hasleton Ph. The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung. Diagn Pathol. 2015; 10: 94.
- Chakraborty RK, Sharma S. Bronchoalveolar Cancer. StatPearls Treasure Island: StatPearls Publishing; 2024. //www.ncbi.nlm.nih.gov/books/NBK513281/
- Suzuki S, Sakurai H, Masai K, et al. Departments of Thoracic Surgery and Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo; and Division of Respiratory Surgery, Nihon University School of Medicine, Tokyo, Japan. A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size. J Thorac Oncol.2017 Dec;12(12):1788-1797. doi: 10.1016/j.jtho.2017.08.015.
- Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol. 2011;24(5):653-64. doi: 10.1038/modpathol.2010.232.
- Tsuta K, Kawago M, Inoue E, et al. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer. 2013;81(3):371-376. doi: 10.1016/j.lungcan.2013.06.012.
- Takahiro M, Morihito O, Man H, et al. Upregulation of Notch2 and Six1 Is Associated with Progression of Early-Stage Lung Adenocarcinoma and a More Aggressive Phenotype at Advanced Stages. doi: 10.1158/1078-0432.CCR-11-1946
- Badalian-Very G, Vergilio JA, Degar BA, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 201016; 116(11):1919-23. doi: 10.1182/blood-2010-04-279083.
- Tomashefski JF, Khiyami A, Kleinerman J. Neoplasms associated with pulmonary eosinophilic granuloma. Arch Pathol Lab Med. 1991;115(5):499-506.
- Egeler RM, Neglia JP, Puccetti DM, et al. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer. 1993:1;71(3):865-73.doi:10.1002/1097-0142(19930201)71:3<;865::aid-cncr2820710334>3.0.co;2-0.
- Atsuhisa T, Akira H, Kei K, et al. Relationship Between Lung Cancer and Mycobacterium Avium Complex Isolated Using Bronchoscopy. Open Respir Med J. 2016; 10: 20–28.
- Lande L, Peterson DD, Gogoi R, et al. Association between pulmonary mycobacterium avium complex infection and lung cancer. J Thorac Oncol 2012; 7:1345-51.
- Fujita K, Yamamoto Y, Kanai O, et al.Development of Myco-bacterium avium complex lung disease in patients with lung cancer on immune checkpoint inhibitors.Open Forum Infect Dis, 2020;7:ofaa067.